Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Opioid Litigations ...
View:
Post by MrMugsy on Jan 23, 2022 11:05am

Opioid Litigations ...

Does pharma investing get uglier before it get better?

$26B in settlement offers from 4 big names.
- $21B from McKesson, Amerisource Bergen and Cardinal Health
- $5B from JNJ

Judging by the market caps of all above - they will survive regardless.

Purdue and Mallinckrodt were not so lucky.

Teve has $23.5B offer on the table - $500M in cash and the rest in meds.
Purdue - judge overturned settlement in Dec 2021 because the deal would protect family and others involved.

CVS/Walgreens/Walmart/Giant Eagle ... no meaningful global offer yet.
Nov 23, 2021 ... A federal jury on Tuesday found three of the nation's biggest pharmacy chains, CVS, Walgreens and Walmart, liable for helping to fuel the U.S. opioid crisis — a decision that's expected to have legal repercussions as thousands of similar lawsuits move forward in courts across the country.

January 26, 2022 ... deadline for political subdivisions to join the deal.

February 25, 2022 ... defendants to decide whether they are going forward with settlement.


---------------------------

Others ???

Endo Pharmaceuticals (could cost them up to $3,000M based on Tennessee offer)
- started with a deal for Tennessee last July for $35M.
- then a deal for New York at $50M.
- Eagle Pharma started shipping vasopressin in direct competition with Endo.
- announced deal for Texas at $63M (4 weeks ago ?)
- announced deal for Florida $65M recently

Endo notes that the primary goal is to achieve a global settlement.  At the same time, Endo is exploring other strategic alternatives in the event it is unable to acheive a global settlement.  Guessing that has to do with the likelihood of a restructuring ????

Heating up ... guessing January 26 and February 25 are important dates re. opioid litigation and next steps.

It should make for some rollercoaster rides with a few pharma names.

I'm sure there's a lot more going on - just so hard to keep track of everything.
Comment by GoldenInvestor on Jan 23, 2022 1:40pm
Mugs, thanks fot the work & info on the timeline & synopsis! looking forward to more GUD things to come! GI
Comment by MrMugsy on Jan 23, 2022 3:41pm
Thanks Buddy !!!
Comment by Chianchin on Jan 23, 2022 6:46pm
Here we go at it again!! Mugsy and Gold "his alias" madly taking the same old bs all over. Can anyone possible imagine writing to yourself and email and minutes later replying back to yourself? fact_This is what Mugsy doe on this board. Yet GUD share prioce continues to languish forever 
Comment by pantono1 on Jan 24, 2022 2:23am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities